drugset / Trial / NCT01433900

Switching From Preserved to Preserved-free Treatments for Glaucoma.

NCT01433900

Phase 3 Unknown 40 enrolled Paolo Fogagnolo
RandomizedParallel-groupOpen-labelTreatment

Summary

A 1-year prospective, randomized, investigator-masked trial comparing the confocal and clinical effects of treatment with unpreserved prostaglandins (tafluprost) versus preserved prostaglandins (latanoprost) in newly-diagnosed glaucoma patients.

Timeline

Start
2012-05
Primary completion
2013-05
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical
Comparator Tafluprost Other / unclassified 0.0015 % Topical

Indications